Protecting Approved Care: AAOS Endorses New Medicare Advantage Bill
Protecting Approved Care: AAOS Endorses New Medicare Advantage Bill
PR Newswire
WASHINGTON, Sept. 15, 2026
WASHINGTON, Sept. 15, 2026 /PRNewswire/ -- Today, the American Association of Orthopaedic Surgeons (AAOS) welcomed the introduction of the Protecting Approved Care Act, new legislation that addresses retroactive reimbursement changes from insurers, also known as clawbacks, in the Medicare Advantage (MA) program. This bipartisan bill, introduced by Reps. Greg Landsman (D-OH) and Bob Onder (R-MO), amends the Medicare statute to require MA organizations to honor original coverage decisions and puts safeguards in place to stop insurers from retroactively denying care or taking back payments already disbursed.
Medicare Advantage insurers routinely require physicians and patients to receive prior authorization (PA) before procedures and services are delivered. However, even when a procedure is approved (or when prior authorization is not required), plans are increasingly retroactively denying coverage, reducing payments, or recouping payments that have already been sent to the MA organization.
"The financial impact of clawbacks on our healthcare system cannot be understated," said AAOS President Wilford K. Gibson, MD, FAAOS. "When insurance companies can shift coverage parameters after care is delivered, patients and physicians are left with unexpected financial burdens months or even years after a previously approved procedure or service is completed. Congress has the unique opportunity to hold insurers accountable by requiring MA organizations to honor their original prior authorizations."
Modernizing Medicare Advantage
Data from the American Medical Association shows that 9 in 10 physicians reported that the prior authorization process somewhat or significantly increases burnout. When insurers claw back an approval, it requires significant administrative work to resolve disputes. Physicians can also be forced to repay funds for services already delivered, adding financial strain.
The consequences are just as widespread for patients. MA patients may suddenly receive unexpected bills for care they thought was covered when the insurer unexpectedly pays less or refuses to pay at all. This particularly harms the low-income seniors and people with disabilities who rely on MA, with 36% of enrollees reporting annual incomes of less than $25,000.
"As an orthopaedic surgeon, I've seen firsthand how clawbacks disrupt physicians' ability to provide high quality and timely care," added Gibson. "The Protecting Approved Care Act will restore the integrity of the prior authorization system while increasing stability for physicians and patients."
About AAOS
The American Association of Orthopaedic Surgeons (AAOS) Office of Government Relations promotes and advocates the viewpoint of the orthopaedic community before federal and state legislative, regulatory and executive agencies. Based in Washington, D.C., with additional staff in the AAOS' headquarters in Rosemont, Illinois, the Office of Government Relations identifies, analyzes and directs all health policy activities and initiatives to position the AAOS as the trusted leaders in advancing musculoskeletal health.
For more information on all AAOS advocacy efforts, visit https://www.aaos.org/advocacy/, and follow AAOS Advocacy on X and LinkedIn.


SOURCE American Association of Orthopaedic Surgeons
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Buy Trading at Big Discounts
This Once-Hot AI Stock Now Looks Deeply Undervalued
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
What 7 Key Market Indicators Are Telling Investors Right Now
